NL6608538A - - Google Patents

Info

Publication number
NL6608538A
NL6608538A NL6608538A NL6608538A NL6608538A NL 6608538 A NL6608538 A NL 6608538A NL 6608538 A NL6608538 A NL 6608538A NL 6608538 A NL6608538 A NL 6608538A NL 6608538 A NL6608538 A NL 6608538A
Authority
NL
Netherlands
Application number
NL6608538A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB37193/63A priority Critical patent/GB1045180A/en
Priority to BR162752/64A priority patent/BR6462752D0/pt
Priority to GB23746/66A priority patent/GB1078887A/en
Priority to US557353A priority patent/US3485842A/en
Application filed filed Critical
Priority to DE19661620135 priority patent/DE1620135A1/de
Priority to FR66107A priority patent/FR1490622A/fr
Priority to BE682829D priority patent/BE682829A/xx
Priority to CH309768A priority patent/CH461510A/fr
Priority to NL6608538A priority patent/NL6608538A/xx
Priority to US641479A priority patent/US3505330A/en
Publication of NL6608538A publication Critical patent/NL6608538A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL6608538A 1963-09-20 1966-06-20 NL6608538A (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB37193/63A GB1045180A (en) 1963-09-20 1963-09-20 Quinazoline derivatives
BR162752/64A BR6462752D0 (pt) 1963-09-20 1964-09-18 Processo para a producao de 2 4 6-triaminoquinazolina e para a producao de compostos de metilamino
GB23746/66A GB1078887A (en) 1963-09-20 1966-05-26 Novel quinazoline compounds and production thereof
US557353A US3485842A (en) 1963-09-20 1966-06-14 Heterocyclic compounds and means for producing the same
DE19661620135 DE1620135A1 (de) 1963-09-20 1966-06-20 Verfahren zur Herstellung von 2,4,6-Triaminochinazolin
FR66107A FR1490622A (fr) 1963-09-20 1966-06-20 Nouveaux dérivés de 2, 4-diaminoqunazoline et procédés pour leur préparation
BE682829D BE682829A (fr) 1963-09-20 1966-06-20
CH309768A CH461510A (fr) 1963-09-20 1966-06-20 Procédé de préparation de quinazolines
NL6608538A NL6608538A (fr) 1963-09-20 1966-06-20
US641479A US3505330A (en) 1963-09-20 1967-05-26 2,4-diaminoquinazoline compounds

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB37193/63A GB1045180A (en) 1963-09-20 1963-09-20 Quinazoline derivatives
BE682829 1966-06-20
DEP0039751 1966-06-20
NL6608538A NL6608538A (fr) 1963-09-20 1966-06-20

Publications (1)

Publication Number Publication Date
NL6608538A true NL6608538A (fr) 1967-12-21

Family

ID=27424853

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6608538A NL6608538A (fr) 1963-09-20 1966-06-20

Country Status (7)

Country Link
US (2) US3485842A (fr)
BE (1) BE682829A (fr)
BR (1) BR6462752D0 (fr)
CH (1) CH461510A (fr)
DE (1) DE1620135A1 (fr)
GB (2) GB1045180A (fr)
NL (1) NL6608538A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980650A (en) * 1972-05-05 1976-09-14 N.V. Koninklijke Pharmaceutische Fabrieken V/H Brocades-Stheeman En Pharmacia 4-Amino-pyrimidine derivatives

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3668205A (en) * 1970-04-20 1972-06-06 Parke Davis & Co Benzylamino quinazolinyl formamidine compounds
US4118561A (en) * 1977-04-06 1978-10-03 American Home Products Corporation 7-(Substituted)-7H-pyrrolo[3,2-f]quinazoline-1,3-diamines
US4208520A (en) * 1978-06-28 1980-06-17 American Home Products Corporation 7-(Substituted)-7H-pyrrolo[3,2-f]quinazoline-1,3-diamines
US4233445A (en) * 1979-07-05 1980-11-11 American Home Products Corporation 7-(Substituted)-7H-pyrrolo[3.2-F]-quinazoline-1,3-diamines
US4376858A (en) * 1980-10-31 1983-03-15 Warner Lambert Company 2-4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline salts
US4578390A (en) * 1981-12-14 1986-03-25 Merck & Co., Inc. Hydroxybenzylamino derivatives as anti-inflammatory agents
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
IL108630A0 (en) * 1993-02-18 1994-05-30 Fmc Corp Insecticidal substituted 2,4-diaminoquinazolines
EP1878717A1 (fr) * 2006-07-14 2008-01-16 Bayer Schering Pharma Aktiengesellschaft Benzylamines, leur procédé de préparation, leur utilisation comme agents anti-inflammatoires
EP2062880A1 (fr) 2007-11-22 2009-05-27 Bayer Schering Pharma Aktiengesellschaft 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, procédé pour leur production et leur utilisation comme agents anti-inflammatoires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1817982A (en) * 1931-08-11 Winfrid hentrich and max habdtmann
US2458214A (en) * 1944-06-26 1949-01-04 Shell Dev Hydrogenation of nitro compounds
US2541717A (en) * 1948-10-18 1951-02-13 Upjohn Co Pterine imines
US2794018A (en) * 1953-08-07 1957-05-28 New quinazoline derivatives
US2888458A (en) * 1954-12-30 1959-05-26 Petrolite Corp Salicylaldehyde and vanillin schiff base derivatives of certain aminoalkyl cyclic amidines
GB935381A (en) * 1958-12-15 1963-08-28 Wellcome Found 2, 4-diaminoquinazolines and their preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980650A (en) * 1972-05-05 1976-09-14 N.V. Koninklijke Pharmaceutische Fabrieken V/H Brocades-Stheeman En Pharmacia 4-Amino-pyrimidine derivatives

Also Published As

Publication number Publication date
GB1078887A (en) 1967-08-09
BR6462752D0 (pt) 1973-08-07
US3485842A (en) 1969-12-23
US3505330A (en) 1970-04-07
BE682829A (fr) 1966-12-01
DE1620135A1 (de) 1970-03-12
GB1045180A (en) 1966-10-12
CH461510A (fr) 1968-08-31

Similar Documents

Publication Publication Date Title
AR142945A1 (fr)
AT260747B (fr)
BE626803A (fr)
BE682829A (fr)
BE616247A (fr)
BE616830A (fr)
BE616967A (fr)
BE637044A (fr)
BE619061A (fr)
BE645913A (fr)
BE612803A (fr)
BE620325A (fr)
BE507458A (fr)
BE608372A (fr)
BE621232A (fr)
BE645694A (fr)
BE644952A (fr)
BE621517A (fr)
BE622160A (fr)
BE623117A (fr)
BE623162A (fr)
BE623220A (fr)
BE623315A (fr)
BE623490A (fr)
BE624070A (fr)